公司資料
Sage Therapeutics, Inc. 股價、新聞與催化劑
- 股票代碼:
- SAGE
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for SAGE.
公司概覽
業務概覽
Sage Therapeutics is a neuroscience company focused on neuropsychiatry, depression, and other CNS disorders.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Sage sits in specialty neuroscience biotech.
商業模式特徵
The company combines commercial execution around CNS medicines with ongoing development in brain-health programs.
生技產業定位
Sage is a CNS catalyst name whose stock tends to move sharply on clinical, commercial, and partnership developments.
未來催化劑
- Sage Therapeutics's catalysts are ZURZUVAE commercialization economics and any next-step CNS update that clarifies whether the company still has a growth path after the reset. The stock remains highly sensitive to whether the launch base can stabilize.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。